Search results for "hospital-acquired"

showing 10 items of 11 documents

Candida thrombophlebitis in children: a systematic review of the literature

2020

Abstract Objective To describe a case of thrombophlebitis associated with Candida infection and to analyze other published reports to define clinical characteristics, prognostic data, diagnostic and therapeutic strategies. Study design A computerized search was performed without language restriction using PubMed and Scopus databases. An article was considered eligible for inclusion if it reported cases with Candida thrombophlebitis. Our case was also included in the analysis. Results A total of 16 articles reporting 27 cases of Candida thrombophlebitis were included in our review. The median age of patients was 4 years. In 10 cases there was a thrombophlebitis of peripheral veins; in the re…

0301 basic medicineAntifungal Agentsmedicine.medical_treatmentReviewThrombophlebitislaw.invention0302 clinical medicineRisk FactorslawAmphotericin BThrombosis.030212 general & internal medicineChildPersistent feverAntifungal therapyChildrenCandidaHospital-acquired infectionsCross InfectionAnticoagulantCandidiasislcsh:RJ1-570PrognosisIntensive care unitThrombosisChild PreschoolCentral venous cathetermedicine.drugmedicine.medical_specialtySepsimedicine.drug_class030106 microbiologySepsis03 medical and health sciencesAmphotericin BSepsisInternal medicinemedicineHumansEnoxaparinbusiness.industryAnticoagulantsThrombosislcsh:PediatricsThrombophlebitisNewbornmedicine.diseaseHospital-acquired infectionParenteral nutritionPhlebitisbusinessItalian Journal of Pediatrics
researchProduct

Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

2022

International audience; BACKGROUND: Mucormycosis is an emerging aggressive mold infection. This study aimed to assess the outcome of hospitalized adults with rhino-orbito-cerebral mucormycosis (ROCM). The secondary objective was to identify prognostic factors in this setting. METHODS: This study was an international, retrospective, multicenter study. Patients’ data were collected from 29 referral centers in 6 countries. All qualified as "proven cases" according to the EORTC/MSGERC criteria. RESULTS: We included 74 consecutive adult patients hospitalized with ROCM. Rhino-orbito-cerebral type infection was the most common presentation (n = 43; 58.1%) followed by rhino-orbital type (…

AdultAntifungal AgentsSurveillanceNeutropeniaEpidemiologyMucormycosiInfectionsHospital-acquired infectionRhino-orbito-cerebral mucormycosisZygomycosis[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyDebridementRisk FactorsDiagnosisOrbital DiseasesRisk Factors.Internal MedicineHumansMucormycosisRhino-orbito-cerebral mucormycosiEye Infections FungalRetrospective Studies
researchProduct

Successful control of a Methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit: a retrospective, before-after study

2013

International audience; Background : Aim of this study was to provide a detailed description of a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak management strategy in the neonatal intensive care unit of a university hospital.MethodsThis was a retrospective, “before-after” study, over two consecutive 18-month periods. The outbreak management strategy was performed by a multidisciplinary team and included: extensive healthcare workers (HCW) involvement, education, continuous hand-hygiene training and active MRSA colonization surveillance. The actions implemented were identified based on an anonymous, voluntary, reporting system, carried out among all the HCW, and regular audit a…

MaleMethicillin-Resistant Staphylococcus aureusmedicine.medical_specialtyNeonatal intensive care unitQuality-improvementVoice BundleCommunity030501 epidemiology[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricsStaphylococcal infectionsmedicine.disease_causeInfant Newborn Diseases03 medical and health sciencesEndemic0302 clinical medicineMedical microbiologyPractices030225 pediatricsIntensive Care Units NeonatalHospital-acquired infectionmedicinePérinatalitéHumansIntensive care medicineRetrospective StudiesCross Infectionbusiness.industryInfant NewbornOutbreakInfantRetrospective cohort studybiochemical phenomena metabolism and nutritionStaphylococcal Infectionsbacterial infections and mycosesmedicine.diseaseNewbornMethicillin-resistant Staphylococcus aureusHospital-acquired infection3. Good healthInfectious DiseasesStaphylococcus aureusFemaleMethicillin ResistanceFrance0305 other medical sciencebusinessResearch Article
researchProduct

Outcomes of Patients Hospitalized with Community-Acquired, Health Care-Associated, and Hospital-Acquired Pneumonia

2009

Background Traditionally, pneumonia has been classified as either community- or hospital-acquired. Although only limited data are available, health care-associated pneumonia has been recently proposed as a new category of respiratory infection. "Health care-associated pneumonia" refers to pneumonia in patients who have recently been hospitalized, had hemodialysis, or received intravenous chemotherapy or reside in a nursing home or long-term care facility. Objective To ascertain the epidemiology and outcome of community-acquired, health care-associated, and hospital-acquired pneumonia in adults hospitalized in internal medicine wards. Design Multicenter, prospective observational study. Sett…

Malemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsHospital-acquired pneumoniaCommunity-acquired pneumoniaRenal DialysisRisk FactorsInternal medicineOutcome Assessment Health CareEpidemiologyPneumonia BacterialInternal MedicinemedicineHumansProspective StudiesIntensive care medicineAgedCross Infectionmedicine.diagnostic_testbusiness.industryMortality rateRespiratory infectionGeneral MedicineOdds ratiomedicine.diseaseLong-Term CareAnti-Bacterial AgentsNursing HomesCommunity-Acquired InfectionsPneumoniaItalyFemaleChest radiographbusinessDelivery of Health Care
researchProduct

More than one in two venous thromboembolism treated in French hospitals occurs during the hospital stays

2016

Objective The objective was to describe the prevalence of venous thromboembolism, pulmonary embolism, and deep vein thrombosis among hospitalized patients and the percentages of those occurring during the hospital stays. Methods French DRG gave now the opportunity to investigate the frequency of venous thromboembolism occurring during the hospital stay. Statistics are issued from the national PMSI MCO databases encoded using the CIM10. Since 2010–2011 it is possible to differentiate the reason for hospital admission from the pathologies which secondly occurred. Any stay with the ICD-10 codes selected was considered as a hospital-occurred thrombosis unless it was the principal diagnosis of t…

Malemedicine.medical_specialtyHospitalized patientsEpidemiologyDeep vein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEpidemiologymedicineHumans030212 general & internal medicineIntensive care medicineCancerbusiness.industryHospital-Acquired Pulmonary EmbolismGeneral MedicineVenous ThromboembolismLength of Stay[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.diseaseThrombosisPulmonary embolismmedicine.anatomical_structureEmergency medicinePulmonary-EmbolismFemaleFranceCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismVenous thromboembolism
researchProduct

Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock.

2011

OBJECTIVE: Septic shock remains a serious disease with high mortality and increased risk of hospital-acquired infection. The prediction of outcome is of the utmost importance for selecting patients for therapeutic strategies aiming to modify the immune response. The aim of this study was to assess the capability of S100A9 messenger RNA in whole blood from patients with septic shock to predict survival and the occurrence of hospital-acquired infection. DESIGN: Cohort study. SETTING: Two intensive care units in a university hospital. SUBJECTS: The study included patients with septic shock (n = 166) and healthy volunteers (n = 44). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: For the pa…

Malemedicine.medical_specialtyTime Factors[SDV]Life Sciences [q-bio]Critical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineIntensive careHospital-acquired infectionmedicineCalgranulin BHumans030212 general & internal medicineRNA MessengerComputingMilieux_MISCELLANEOUS030304 developmental biologyAged0303 health sciencesCross InfectionSeptic shockbusiness.industryOdds ratioMiddle Agedmedicine.diseaseShock Septic3. Good health[SDV] Life Sciences [q-bio]Intensive Care Units[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieShock (circulatory)Predictive value of testsBiomarker (medicine)[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessBiomarkersCohort studyCritical care medicine
researchProduct

Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.

1990

The efficacy and safety of ceftazidime and imipenem in patients with severe infections was compared in a randomized multi-centre trial. Patients on assisted respiration with clinical signs of pneumonia or septicaemia who had been in hospital for at least 3 days were studied. Twenty-one patients were treated with ceftazidime, 24 with imipenem. The mean duration of treatment was 9 days in both groups. At the end of the trial 17 patients (81%) of the ceftazidime group and 16 patients (67%) in the imipenem group were clinically cured or showed marked improvement. The bacteriological results showed an eradication of the causative pathogens in 17 of 21 cases in the ceftazidime group and 13 of 19 …

Microbiology (medical)Malemedicine.medical_specialtyImipenemCeftazidimeHospital-acquired pneumoniaCeftazidimeInternal medicineSepsismedicineHumansMulticenter Studies as TopicIn patientRandomized Controlled Trials as TopicCross Infectionbusiness.industryImipenem/cilastatinGermany WestGeneral MedicinePneumoniaMiddle Agedbacterial infections and mycosesmedicine.diseaseRespiration ArtificialSurgeryClinical trialPneumoniaDrug CombinationsImipenemInfectious DiseasesCilastatinFemalebusinessmedicine.drugThe Journal of hospital infection
researchProduct

Factors influencing hospital infection control policies in Italian hospitals

2003

A study was undertaken to determine the resources available in Italian hospitals for the control of nosocomial infections and the factors favouring a successful approach. During January-May 2000 a questionnaire about infection control was sent to the hospital health director of all Italian National Health System hospitals treating acute patients and with more than 3500 admissions in 1999. An active programme was defined as a hospital infection control committee (HICC) meeting at least four times in 1999, the presence of a doctor with infection control responsibilities, a nurse employed in infection control and at least one surveillance activity and one infection control guideline issued or …

Microbiology (medical)medicine.medical_specialtyPediatricsMultivariate analysisregional policiesSettore MED/42 - Igiene Generale E ApplicataHospital-acquired infectionmedicineHumansInfection controlfactor influencingHealth policyhospital-acquired infection; infection control; regional policiesResponse rate (survey)Cross InfectionInfection Controlhospital-acquired infectionInfection Control Practitionersbusiness.industryPublic healthInfection control; hospital-acquired infection; regional policiesGeneral MedicineGuidelineOdds ratiomedicine.diseaseOrganizational PolicyLogistic ModelsInfectious DiseasesItalyHospital Bed CapacityPopulation SurveillanceFamily medicineMultivariate AnalysisHospital-acquired infection; Infection control; Regional policies; Microbiology (medical); Infectious DiseasesbusinessJournal of Hospital Infection
researchProduct

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.

2023

Purpose: In the critically ill, hospital-acquired bloodstream infections (HA-BSI) are associated with significant mortality. Granular data are required for optimizing management, and developing guidelines and clinical trials. Methods: We carried out a prospective international cohort study of adult patients (≥ 18 years of age) with HA-BSI treated in intensive care units (ICUs) between June 2019 and February 2021. Results: 2600 patients from 333 ICUs in 52 countries were included. 78% HA-BSI were ICU-acquired. Median Sequential Organ Failure Assessment (SOFA) score was 8 [IQR 5; 11] at HA-BSI diagnosis. Most frequent sources of infection included pneumonia (26.7%) and intravascular catheters…

antibiotic resistancebloodstream infectionhospital-acquiredbacteremiaCritical Care and Intensive Care Medicineantibiotic resistance ; bacteremia ; bloodstream infection ; hospital-acquired.
researchProduct

Krūšu rajonā novietoto sensoru pielietojums slimnīcā iegūto izgulējumu novēršanas pasākumos

2020

Darba aktualitāte: Izgulējumi ir viena no visizplatītākajām slimnīcā iegūtām slimībām, kas var novest līdz dzīves pasliktināšanai un pat nāvei. Profilaktiskie pasākumi var samazināt izgulējumu biežumu veidošanos. Darba mērķis: Izvērtēt valkājamo sensoru nozīmi slimnieka pozas vērtēšanā 24 stundu laika periodā pētot pacienta pagriešanās laiku un apjomu. Materiāli un metodes: Prospektīvājā pētijumā tika pētīti RAKUS Stacionāra ”Biķernieki” iegūti dati no 15 valkājamiem Movesense sensoriem, kas tika novietoti uz pacienta krūšu kaula laika posmā no 10.02.20 līdz 12.03.20, pēc kā tika ieviesta ārkārtējā situācija un visi klīniskie pētījumi tika apstādināti. Sensors tika novietots uz krūšu kaula …

hospital-acquired bedsoreswearable sensorspozicionēšanas kartesslimnīcā iegūtie izgulējumiMedicīnavalkājamie sensori
researchProduct